A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Kian Sadeghi, the 25-year-old founder and CEO at Nucleus Genomics, tells "CBS Mornings" that parents have every right to select the qualities and traits they desire in their child.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ST-503, an investigational ...

Explore the growing AI supercomputer market, projected to rise from 3.1 billion USD in 2025 to 15.4 billion USD by 2034.

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance at a resilient ...

As a prominent force in DNA sequencing and array-based technologies, Illumina has been deeply committed to China for two decades. Despite market challenges, Illumina remains steadfast in its mission ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...